| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |